Business Description
Philogen SpA
ISIN : IT0005373789
Total Employee Number:
214Compare
Compare
Traded in other countries / regions
PHIL.Italy78Q.GermanyPHILm.UK IPO Date
2021-03-10Description
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 34.85 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.04 | |||||
Interest Coverage | 697.57 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 13.96 | |||||
Beneish M-Score | -0.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 137.3 | |||||
3-Year Book Growth Rate | 56.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56 | |||||
9-Day RSI | 57.66 | |||||
14-Day RSI | 57.49 | |||||
3-1 Month Momentum % | 1.2 | |||||
6-1 Month Momentum % | -1.17 | |||||
12-1 Month Momentum % | 6.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.76 | |||||
Quick Ratio | 7.7 | |||||
Cash Ratio | 7.39 | |||||
Days Inventory | 241.32 | |||||
Days Sales Outstanding | 1.16 | |||||
Days Payable | 826.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.01 | |||||
Forward Dividend Yield % | 3.01 | |||||
5-Year Yield-on-Cost % | 2.98 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 3.14 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 98.31 | |||||
Operating Margin % | 82.11 | |||||
Net Margin % | 73.07 | |||||
EBITDA Margin % | 84.23 | |||||
FCF Margin % | 84.09 | |||||
OCF Margin % | 85.25 | |||||
ROE % | 107.94 | |||||
ROA % | 90.05 | |||||
ROIC % | 531.48 | |||||
3-Year ROIIC % | 1887.64 | |||||
ROC (Joel Greenblatt) % | 1043.1 | |||||
ROCE % | 115.52 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 4.32 | |||||
Forward PE Ratio | 37.45 | |||||
PE Ratio without NRI | 4.38 | |||||
Price-to-Owner-Earnings | 3.89 | |||||
PS Ratio | 3.18 | |||||
PB Ratio | 2.65 | |||||
Price-to-Tangible-Book | 2.66 | |||||
Price-to-Free-Cash-Flow | 3.77 | |||||
Price-to-Operating-Cash-Flow | 3.72 | |||||
EV-to-EBIT | 2.35 | |||||
EV-to-EBITDA | 2.31 | |||||
EV-to-Revenue | 1.96 | |||||
EV-to-FCF | 2.4 | |||||
Price-to-GF-Value | 0.11 | |||||
Price-to-Graham-Number | 0.72 | |||||
| Price-to-Net-Current-Asset-Value | 2.97 | |||||
| Price-to-Net-Cash | 3.14 | |||||
Earnings Yield (Greenblatt) % | 42.5 | |||||
FCF Yield % | 26.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Philogen SpA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 314.325 | ||
| EPS (TTM) (€) | 5.7 | ||
| Beta | -0.3874 | ||
| 3-Year Sharpe Ratio | 0.64 | ||
| 3-Year Sortino Ratio | 1.11 | ||
| Volatility % | 23.09 | ||
| 14-Day RSI | 57.49 | ||
| 14-Day ATR (€) | 0.80712 | ||
| 20-Day SMA (€) | 22.0675 | ||
| 12-1 Month Momentum % | 6.55 | ||
| 52-Week Range (€) | 18.86 - 25.7 | ||
| Shares Outstanding (Mil) | 40.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Philogen SpA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Philogen SpA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.700000 Cash Dividend | 2026-05-18 | 21.25 (-1.39%) |
Show
Entries
Philogen SpA Frequently Asked Questions
What is Philogen SpA(FRA:78Q)'s stock price today?
The current price of FRA:78Q is €23.25. The 52 week high of FRA:78Q is €25.70 and 52 week low is €18.86.
When is next earnings date of Philogen SpA(FRA:78Q)?
The next earnings date of Philogen SpA(FRA:78Q) is .
Does Philogen SpA(FRA:78Q) pay dividends? If so, how much?
The Dividend Yield %  of Philogen SpA(FRA:78Q) is 3.01% (As of Today), Highest Dividend Payout Ratio of Philogen SpA(FRA:78Q) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Philogen SpA(FRA:78Q) is 3.01%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Philogen SpA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers